| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Antigenic Specificity | IL1 Alpha |
|---|
| Clone | HuMab X3 |
|---|
| Host Species | Human |
|---|
| Reactive Species | human |
|---|
| Isotype | IgG4k |
|---|
| Format | purified |
|---|
| Size | 100μg/50μg |
|---|
| Concentration | n/a |
|---|
| Applications | Binding to IL1a and not to IL1 nor IL1Ra, Neutralizing biological effects of natural and recombinant IL1a, Inhibition of IL1a binding to IL1 receptors |
|---|
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
|---|
| Description | Interleukin-1 (IL-1) defines two polypeptides, IL-1α and IL-1β, that possess a wide spectrum of biological effects. Two natural antagonists of IL-1 action have been characterized: the IL-1 receptor antagonist (IL-1Ra) and a soluble form of the type II IL-1 receptor. Neutralizing autoantibodies to IL-1α have also been detected in sera of healthy individuals and patients with autoimmune or inflammatory diseases. By combining CD40-activation and Epstein-Barr virus-immortalization of B lymphocytes from individuals with circulating anti-IL-1α, a natural anti-IL-1α monoclonal autoantibody was developed that bound specifically to human IL-1α, but not to IL-1β and IL-1Ra, with a high affinity (Kd = 1.2 x 10-10 M). HuMAb X3 inhibited IL-1α binding to IL-1 receptors and neutralized biological activities of both recombinant and natural forms of IL-1α. This high affinity neutralizing anti-IL-1α human autoantibody can function as a third type of IL-1 antagonist. (Garrone P et al, Mol Immunol 1996, 33 (7-8), 649-58 ; Guillot-Chene P, Lebecque S, Rigal D, Annales Pharmaceutiques Francaises, 06/2009, 67 (3) 182-6). |
|---|
| Immunogen | n/a |
|---|
| Other Names | Interleukin, Hematopoietin 1 |
|---|
| Gene, Accession # | n/a |
|---|
| Catalog # | DDX0710 |
|---|
| Price | |
|---|
| Order / More Info | IL1 Alpha Antibody from DENDRITICS SAS |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|